[go: up one dir, main page]

DK0873405T3 - Ekspressionsforøgende sekvenselementer (EASE) til eukaryote ekspressionssystemer - Google Patents

Ekspressionsforøgende sekvenselementer (EASE) til eukaryote ekspressionssystemer

Info

Publication number
DK0873405T3
DK0873405T3 DK97902909T DK97902909T DK0873405T3 DK 0873405 T3 DK0873405 T3 DK 0873405T3 DK 97902909 T DK97902909 T DK 97902909T DK 97902909 T DK97902909 T DK 97902909T DK 0873405 T3 DK0873405 T3 DK 0873405T3
Authority
DK
Denmark
Prior art keywords
ease
expression
sequence elements
enhancing sequence
eukaryotic
Prior art date
Application number
DK97902909T
Other languages
English (en)
Inventor
Arvia E Morris
Chi-Chang Lee
James N Thomas
Original Assignee
Immunex Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunex Corp filed Critical Immunex Corp
Application granted granted Critical
Publication of DK0873405T3 publication Critical patent/DK0873405T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/30—Vector systems having a special element relevant for transcription being an enhancer not forming part of the promoter region
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron
    • C12N2840/203—Vectors comprising a special translation-regulating system translation of more than one cistron having an IRES

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Amplifiers (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Control Of Indicators Other Than Cathode Ray Tubes (AREA)
  • Error Detection And Correction (AREA)
DK97902909T 1996-01-11 1997-01-10 Ekspressionsforøgende sekvenselementer (EASE) til eukaryote ekspressionssystemer DK0873405T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US58650996A 1996-01-11 1996-01-11
EP97902909A EP0873405B1 (en) 1996-01-11 1997-01-10 Expression augmenting sequence elements (ease) for eukaryotic expression systems

Publications (1)

Publication Number Publication Date
DK0873405T3 true DK0873405T3 (da) 2005-01-17

Family

ID=24346030

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97902909T DK0873405T3 (da) 1996-01-11 1997-01-10 Ekspressionsforøgende sekvenselementer (EASE) til eukaryote ekspressionssystemer

Country Status (14)

Country Link
US (3) US6027915A (da)
EP (1) EP0873405B1 (da)
JP (1) JP3495375B2 (da)
KR (1) KR19990077015A (da)
AT (1) ATE275628T1 (da)
AU (1) AU708981B2 (da)
CA (1) CA2241174C (da)
DE (1) DE69730592T2 (da)
DK (1) DK0873405T3 (da)
ES (1) ES2227669T3 (da)
NO (1) NO323277B1 (da)
NZ (1) NZ330926A (da)
PT (1) PT873405E (da)
WO (1) WO1997025420A1 (da)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6596514B2 (en) * 1996-01-11 2003-07-22 Immunex Corporation Expression augmenting sequence elements (EASE) for eukaryotic expression systems
CA2241174C (en) * 1996-01-11 2006-09-12 Immunex Corporation Expression augmenting sequence elements (ease) for eukaryotic expression systems
DE122010000048I1 (de) 1996-12-23 2011-05-05 Immunex Corp Ligand für rezeptor aktivator of nf-kappa b, ligand ist mitglied der tnf superfamilie
US6521419B1 (en) 1998-09-22 2003-02-18 Kanakaraju Koduri Expression vectors containing hot spot for increased recombinant protein expression in transfected cells
US6800457B2 (en) 1998-09-22 2004-10-05 Bristol-Myers Squibb Company Expression vectors containing hot spot for increased recombinant protein expression in transfected cells
DK1222298T3 (da) * 1999-10-13 2006-04-10 Immunex Corp Vektorer og fremgangsmåder til rekombinant proteinekspression
EP2248828A1 (en) 1999-12-23 2010-11-10 ZymoGenetics, Inc. Method for treating inflammation
KR100450266B1 (ko) * 2002-01-16 2004-09-30 주식회사 엘지생명과학 유전자 발현 동물세포 제조용 바이시스트로닉 벡터 및이를 포함하는 세포주 그리고 이를 이용한 항체단백질의생산방법
WO2003087393A2 (en) * 2002-04-09 2003-10-23 Global Biotech Inc. Human tissue urokinase type plasminogen activator production
AU2003278695A1 (en) * 2002-05-28 2004-02-02 Maxygen, Inc. Nucleic acid vectors
JP2005031812A (ja) * 2003-07-08 2005-02-03 Toshiba Corp 画像形成装置およびその制御方法
KR100807312B1 (ko) 2005-10-22 2008-02-28 (주)리즈바이오텍 재조합 인간 인슐린 유사 성장 인자 결합 단백질-3의 생산정제 방법
US20080124760A1 (en) * 2006-07-26 2008-05-29 Barbara Enenkel Regulatory Nucleic Acid Elements
AU2007294731B2 (en) 2006-09-13 2014-04-17 Abbvie Inc. Cell culture improvements
EP2500416A1 (en) 2006-09-13 2012-09-19 Abbott Laboratories Cell culture improvements
SG182953A1 (en) 2007-03-30 2012-08-30 Abbott Lab Recombinant expression vector elements (reves) for enhancing expression of recombinant proteins in host cells
WO2010024927A2 (en) 2008-08-28 2010-03-04 The Research Foundation Of State University Of New York Treatment of amyloidoses using myelin basic protein and fragments thereof
JP4568378B2 (ja) * 2008-08-29 2010-10-27 東洋紡績株式会社 遺伝子発現安定化エレメント
AU2009319772A1 (en) 2008-11-26 2010-06-03 Centocor Research & Development, Inc. Compositions and methods for regulating collagen and smooth muscle actin expression by SERPINE2
US9284563B2 (en) 2009-06-15 2016-03-15 Cellagenics B.V. Stringent selectable markers
WO2011159157A1 (en) 2010-06-15 2011-12-22 Cellagenics B.V. Novel intergenic elements for enhancing gene expression
KR101599138B1 (ko) 2014-06-17 2016-03-03 한국생명공학연구원 재조합 단백질 발현 증진을 위한 유전자 절편을 포함하는 벡터 및 이의 용도
WO2016003368A1 (en) * 2014-07-01 2016-01-07 Agency For Science, Technology And Research Optimized vectors for the production of recombinant proteins
WO2020068631A1 (en) * 2018-09-24 2020-04-02 Merck Sharp & Dohme Corp. Expression vectors for eukaryotic expression systems
KR20210101270A (ko) 2018-12-10 2021-08-18 암젠 인크 돌연변이 피기백 트랜스포사제
EP3898965A4 (en) 2018-12-21 2022-10-12 Merck Sharp & Dohme Corp. Expression vectors for eukaryotic expression systems
AU2020288407A1 (en) * 2019-06-07 2021-12-16 Biocon Biologics Limited Mammalian expression vectors
TW202233660A (zh) 2020-10-30 2022-09-01 美商安進公司 過表現胰島素樣生長因子受體突變體以調節ｉｇｆ補充
WO2022140389A1 (en) 2020-12-22 2022-06-30 Amgen Inc. Cell culture method
WO2022261299A1 (en) 2021-06-10 2022-12-15 Amgen Inc. Engineered nrg-1 variants with improved selectivity toward erbb4 but not against erbb3
TW202328442A (zh) 2021-09-10 2023-07-16 美商安進公司 平臺宿主對ｉｇｆ—培養基之適應
WO2025024295A1 (en) 2023-07-21 2025-01-30 Amgen Inc. Vectors incorporating a combination of promoters driving selectable marker expression

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3730246A1 (de) * 1987-09-09 1989-06-01 Boehringer Mannheim Gmbh Expressionsvektor und verfahren zur expression von heterologen proteinen in saeugerzellen
CA2241174C (en) * 1996-01-11 2006-09-12 Immunex Corporation Expression augmenting sequence elements (ease) for eukaryotic expression systems

Also Published As

Publication number Publication date
NO323277B1 (no) 2007-02-26
NZ330926A (en) 1999-11-29
US6027915A (en) 2000-02-22
DE69730592D1 (de) 2004-10-14
EP0873405A4 (en) 2001-10-17
CA2241174A1 (en) 1997-07-17
EP0873405A1 (en) 1998-10-28
US6312951B1 (en) 2001-11-06
AU708981B2 (en) 1999-08-19
PT873405E (pt) 2005-01-31
NO983102D0 (no) 1998-07-03
AU1697397A (en) 1997-08-01
JP2000503205A (ja) 2000-03-21
ATE275628T1 (de) 2004-09-15
WO1997025420A1 (en) 1997-07-17
NO983102L (no) 1998-09-08
JP3495375B2 (ja) 2004-02-09
ES2227669T3 (es) 2005-04-01
KR19990077015A (ko) 1999-10-25
EP0873405B1 (en) 2004-09-08
CA2241174C (en) 2006-09-12
US6309841B1 (en) 2001-10-30
DE69730592T2 (de) 2005-09-29

Similar Documents

Publication Publication Date Title
DK0873405T3 (da) Ekspressionsforøgende sekvenselementer (EASE) til eukaryote ekspressionssystemer
HUP9700428A2 (hu) Célsejtspecifikus vektorok gének beépítésére, a vektorokat tartalmazó gyógyászati készítmények és azok alkalmazása
SV1997000018A (es) Proteinas inhibisoras (bikunin humano)
ATE500323T1 (de) Subtilisin-variante
BR0009393A (pt) Polipeptìdeo, sequência de ácido nucleico isolada, construção de ácido nucleico, vetor de expressão recombinante, célula hospedeira recombinante, método para a produção do polipeptìdeo, uso de um polipeptìdeo, e, composição detergente
DK1222298T3 (da) Vektorer og fremgangsmåder til rekombinant proteinekspression
ES2109924T3 (es) Metodo rapido, versatil y simple de expresion de genes en celulas eucarioticas.
WO1996034107A3 (en) Antiviral proteins, dna coding sequences therefor, and uses thereof
BG102554A (en) Vectors and methods for gene transfer into cells
AU2001278797A1 (en) Expression vector using for animal cell
DE69826661D1 (de) Antitumorale zusammenstellung von immunogene polypetiden mit veränderter zellokalisierung
ATE440611T1 (de) Virale vektoren
WO2002061097A8 (en) Cloning vectors and vector components
WO2002006457A3 (en) Novel lipase genes
DE69939327D1 (de) Funktionelle antagonisten von hedgehog-aktivität
HUP9904203A2 (hu) Eljárás hosszú, ismétlődő DNS-szekvenciák stabil klónozására
NZ304570A (en) Neurone-restrictive silencer factor proteins, nucleic acids and antibodies thereto
WO1995006735A3 (en) Nucleotide sequences for novel protein tyrosine phosphatases
FI962268A0 (fi) Homologinen, rekombinanttinen vasta-aineilmentämisjärjestelmä rottien tai hiirien soluille
ATE384787T1 (de) Tripeptidyl-aminopeptidase
PT1025245E (pt) Criacao rapida de linhas celulares estaveis de mamifero produzindo elevados iiveis de proteinas recombinantes
EP1147211A4 (en) HIGH EXPRESSION OF A HETEROLOGICAL PROTEIN WITH RARE CODONS
AU6724794A (en) GRB3-3 gene, its variants and their uses
ATE288488T1 (de) Zusammensetzungen und verfahren zur eliminierung unerwünschter zellen
AU2001238064A1 (en) 18477, a human protein kinase and uses therefor